CoChat

Structured Risk Assessment for First-in-Human Studies

van Iersel, Mattheus Thijs, Greenberg, Howard E., Westrick, Mary L. · 2017 · Therapeutic Innovation & Regulatory Science

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

We describe a structured risk assessment and risk mitigation process that is currently used to evaluate proposed first-in human (FiH) studies. This process balances the inherent risks of an FiH study with maximal protection of subjects. Risk assessment should consider all available data, carefully identifying aspects that may lead to risk for healthy subjects. A structured risk assessment avoids omissions and promotes consistency. Such a risk assessment should be performed for Investigational Products as well as for challenge agents and study procedures. Careful risk assessment recognizes gaps of knowledge and emphasizes that FiH studies are tolerability, not toxicity, studies.

Overview

Integrity signals

Registry

Crossref · 10.1177/2168479017705156

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Research works printed but not linked: 2

  1. Mezher M. EMA begins review of first-in-human trial safety following patient death, 2016. http://www.raps.org/Regulatory-Focus/News/2016/05/27/25030/EMA-Begins-Review-of-First-in-Human-Trial-Safety-Following-Patient-Death/. Accessed November 7, 2016.
  2. Peremans A. Need for a uniform European registration system for volunteer participation? Paper presented at: Joint Conference of European Human Pharmacology Societies, Berlin 2011.

Cited by

See all 7

Metadata

Authors
van Iersel, M. T., Greenberg, H. E., & Westrick, M. L.
Affiliations
University of Wisconsin–Madison (US)
Venue
Therapeutic Innovation & Regulatory Science
Published
2017-05
Volume
51
Issue
3
Pages
288-297
ISSN
  • 2168-4790 (ISSN-L)
  • 2168-4804
OpenAlex
W2610644622
Cited by
7
References
25
Citations by year
2026: 1 · 2025: 1 · 2021: 1 · 2018: 1 · 2017: 3
FWCI
1.03
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Therapeutic Innovation & Regulatory Science (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
first-in-human study, risk assessment, risk mitigation, healthy volunteers, investigational products

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structured Risk Assessment for First-in-Human Studies. https://app.cochat.ai/papers/10.1177/2168479017705156
The paper
van Iersel, M. T., Greenberg, H. E., & Westrick, M. L. (2017). Structured Risk Assessment for First-in-Human Studies. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1177/2168479017705156

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.